Use of Filgrastim and Pegfilgrastim to Support Delivery of Chemotherapy: Twenty Years of Clinical Experience

By Renwick William  

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 175-186

Adis International

Access to resources Recommend Favorite

Oprelvekin: A Review of its Pharmacology and Therapeutic Potential in Chemotherapy-Induced Thrombocytopenia

By Wilde M.I.   Faulds D.  

BioDrugs, Vol. 10, Iss. 2, 1998-08 ,pp. : 159-171

Adis International

Access to resources Recommend Favorite

Implementation of best practice for chemotherapy-induced nausea and vomiting in an acute care setting

By Chung Su Kyoung   Ahn Mee Jung   Yoo Jae Yong   Choi Mona   Hyang Na   Woo So Rah   Kim So-Sun   Kim Sun Ah   Oh Eui Geum  

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 1, 2011-03 ,pp. : 32-38

Blackwell Publishing

Access to resources Recommend Favorite

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

By Schwartzberg L.   Shiffman R.   Tomita D.   Stolshek B.   Rossi G.   Adamson R.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2781-2796

Elsevier

Access to resources Recommend Favorite

Spotlight on Darbepoetin Alfa in the Treatment of Anemia in Patients with Cancer Receiving Chemotherapy

By Siddiqui M. Asif A.   Keating Gillian M.  

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 321-323

Adis International

Access to resources Recommend Favorite